INM
InMed Pharmaceuticals Inc

6,483
Loading...
Loading...
InMed Pharmaceuticals, Inc. engages in developing small molecule drug candidates targeting the CB1/CB2 receptors. It operates through the InMed Pharma and BayMedica Commercial segments. The InMed Pharma segment focuses on research and development. The BayMedica Commercial segment refers to manufacturing technologies to produce and commercialize bulk cannabinoids for sale as ingredients in the health and wellness industry. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13

Frequently Asked Questions

What is Market Cap of InMed Pharmaceuticals Inc?
What is the 52-week high for InMed Pharmaceuticals Inc?
What is the 52-week low for InMed Pharmaceuticals Inc?
What is InMed Pharmaceuticals Inc stock price today?
What was InMed Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of InMed Pharmaceuticals Inc?
What is the Price-to-Book ratio of InMed Pharmaceuticals Inc?
What is the 50-day moving average of InMed Pharmaceuticals Inc?
How many employess does InMed Pharmaceuticals Inc has?

Latest INM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.